Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-04-26
2011-04-26
Audet, Maury (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S328000, C530S327000, C530S387700, C514S001100, C436S006000, C424S138100, C435S007230
Reexamination Certificate
active
07932229
ABSTRACT:
The present invention provides new methods and uses of peptides in effecting a reduction in mammary cell number. The discovery that these peptides reduce mammary cell number further enables the use of these peptides in the treatment of cancer where the peptides can be used to reduce cell number and accordingly reduce or prevent tumour development. The inventor has further shown that the peptides have specific utility in the treatment of breast cancer.
REFERENCES:
patent: 2004/0097714 (2004-05-01), Maubois et al.
patent: 2006/0178311 (2006-08-01), Wilde et al.
patent: 1 568 377 (2005-08-01), None
patent: WO 01/64234 (2001-09-01), None
patent: WO 03/006500 (2003-01-01), None
patent: WO 03/018606 (2003-03-01), None
patent: WO 2004/113378 (2004-12-01), None
Lahov, et al. “Antibacterial and Immunostimulating Casein-Derived Substances From Milk: Casecidin, Isracidin Peptides”,Food and Chemical Toxicology, XX, XX, vol. 34, No. 1, 1996, pp. 131-145.
Audet Maury
AvantiCell Science Ltd
Drinker Biddle & Reath LLP
LandOfFree
Compositions and methods for the control of mammary cell number does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the control of mammary cell number, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the control of mammary cell number will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2659348